Glycogen storage disease type IV
From Wikipedia, the free encyclopedia
| Glycogen storage disease type IV | |
|---|---|
| Classification and external resources | |
Glycogen |
|
| ICD-10 | E74.0 |
| ICD-9 | 271.0 |
| OMIM | 232500 |
| DiseasesDB | 5303 |
| eMedicine | med/910 ped/97 |
| MeSH | D006011 |
Glycogen storage disease is a rare hereditary metabolic disorder.
Contents |
[edit] Synonyms
It is also known as:-
- Glycogenosis type IV,
- Glycogen Branching Enzyme Deficiency (GBED),
- polyglucosan body disease.
- Amylopectinosis
[edit] Eponym
The eponym "Andersen's disease" is sometimes used, for Dorothy Hansine Andersen.[1][2][3]
[edit] Human pathology
It is a result of the absence of the glycogen branching enzyme amylo-1,4-1,6 transglucosidase, which is critical in the production of glycogen. This leads to very long unbranched glucose chains being stored in glycogen. The long unbranched molecules (known as amylose) have a low solubility which leads to glycogen precipitation in the liver. These deposits subsequently build up in the body tissue, especially the heart and liver. The probable end result is cirrhosis and death by age 5 years.
[edit] Horse pathology
See main article: Glycogen branching enzyme deficiency
[edit] References
[edit] External links
|
|||||||||||||||||||||||||||||||||||||||||||
| This article about an endocrine, nutritional or metabolic disease is a stub. You can help Wikipedia by expanding it. |
| This genetic disorder article is a stub. You can help Wikipedia by expanding it. |